EGFR and Barrett esophagus: Our results are consistent with the findings of a prospective study by Vallböhmer et al. who found no difference between EGFR mRNA expression in 59 patients with BE, dysplasia, or EAC (case group) and 16 patients with normal esophageal pH and no histological evidence of mucosal injury (control group).